Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.
Department of Ophthalmology and Pacific Vision Foundation, California Pacific Medical Center, San Francisco, California, United States of America. dheidenpea@yahoo.com
David
D
Heiden
Nathan
N
Ford
David
D
Wilson
William R
WR
Rodriguez
Todd
T
Margolis
Bart
B
Janssens
Martha
M
Bedelu
Nini
N
Tun
Eric
E
Goemaere
Peter
P
Saranchuk
Kalpana
K
Sabapathy
Frank
F
Smithuis
Emmanuel
E
Luyirika
W Lawrence
WL
Drew
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D017954:Africa South of the Sahara / Q000453:epidemiology; D044966:Anti-Retroviral Agents / Q000191:economics / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use*; D001210:Asia, Southeastern / Q000453:epidemiology; D001766:Blindness / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D018791:CD4 Lymphocyte Count; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D003906:Developing Countries; D004196:Disease Outbreaks; D016527:Drug Costs; D015774:Ganciclovir / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D006297:Health Services Accessibility; D006801:Humans; D008403:Mass Screening; D009887:Ophthalmoscopy; D016730:Program Development; D016896:Treatment Outcome; D000077562:Valganciclovir
D044966:Anti-Retroviral Agents; D000998:Antiviral Agents; D000077562:Valganciclovir; D015774:Ganciclovir